Menu

Why I Had My Sense of Flavor Genotyped

One person’s quest to get to the bottom of the unique way he experiences food

May 1, 2017
Bob Holmes

W.W. Norton & Company, April 2017 As soon as I decided to write a book on the science of flavor, I knew I wanted to have myself genotyped. Every one of us, I learned through my preliminary research for Flavor: The Science of Our Most Neglected Sense, probably has a unique set of genes for taste and odor receptors. So each person lives in their own flavor world. I wanted to know what my genes said about my own world. Sure enough, there was a lesson there—but not the one I expected.

Our senses of smell and taste detect chemicals in the environment as they bind to receptors on the olfactory epithelium in the nose or on taste buds studding the mouth. From these two inputs, plus a few others, the brain assembles the compound perception we call flavor. Taste is pretty simple: basically, one receptor type each for sweet, sour, salty, and the savory taste called umami, and a family of maybe 20 or more bitter receptors, each of which is sensitive to different chemicals. Smell, on the other hand, relies on more than 400 different odor receptor types, the largest gene family in the human genome. Variation in any of these genes—and, probably, many other genes that affect the pathways involved in taste or smell—should affect how we perceive the flavors of what we eat and drink.

Hence the genotyping. One April morning a few years ago, I drooled into a vial and sent that DNA sample off to the Monell Chemical Senses Center in Philadelphia, home to what is likely the world’s biggest research group dedicated to the basic science of flavor. A few months later, I visited Monell to take a panel of perceptual tests and compare the results to my genetic profile.

I had already learned that I’m a so-called supertaster from another researcher, who had offered that conclusion after counting the taste-bud-bearing fungiform papillae on my tongue. “Supertaster” is an often-misused term for someone who is acutely sensitive to bitter tastes, and probably other ones as well. Despite the “super,” it’s generally not something to be proud of—because their taste sensations are so intense, supertasters often confine themselves to narrow, bland diets. But not me. I love all sorts of intense, bitter foods: black coffee, highly hopped beers, bitter green vegetables like broccoli rabe and collard greens.  

My genotype yielded equally puzzling results. My version of the sweet-receptor gene is less responsive than normal, which should make me prefer sweeter food and drinks to get the same flavor bang. And sure enough, on the perceptual tests I’d rated a 12 percent sugar solution as highly pleasant, while many people find it far too sweet. But that doesn’t match my eating habits: I’m generally indifferent to dessert, and I detest sweetened coffee or tea.

The picture wasn’t any clearer for the few odor-receptor genes I was tested for. Most of the time, my ratings of the pleasantness and intensity of odors like earthy 2-ethylfenchol or sweaty isovaleric acid aligned poorly with the predictions based on my genes for the relevant odor receptors.

So why don’t my genes match my culinary preferences? The reason, probably, is that nurture matters at least as much as nature in molding anyone’s flavor destiny. Like many people, I’ve learned to like my coffee unsweetened, and that main courses are more interesting than desserts. We’re also good at learning to link flavors to consequences. We associate coffee’s bitterness with the wake-up jolt of caffeine it delivers, so what was once a warning—bitterness—becomes a beacon. And we pair the taste of beer or gin and tonic with the pleasure we get from an evening out with friends. With associations like that, it’s no wonder so many of us love what are, objectively speaking, such nasty, bitter flavors. 

Bob Holmes is a correspondent for New Scientist. Read an excerpt of Flavor: The Science of Our Most Neglected Sense.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.